knowledge -WSS

knowledge

author：knowledge 2025-09-27 09:54:18 - browse：56168

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Activists slam private health insurers over coverage restrictions

WSS

Medicare proposal to cover medical devices draws a mixed reaction

Physicians aren't 'burning out.' They're suffering from moral injury

Flint parents haunted by uncertainty, fears of lead poisoning

Novavax promises a turnaround & Lilly roils the obesity market

Medicare proposal to cover medical devices draws a mixed reaction

As demand for Covid shots wanes, Moderna seeks its next success

focus

knowledge

focus

Anesthesiologist group: stop taking Ozempic before surgery

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

BioMarin wins approval for gene therapy to treat hemophilia A

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Guidelines to prevent youth baseball injuries need more muscle

How to save PrEP access — and even expand it

Tori Bowie and the unacceptable rates of Black maternal death

Psychedelics group wrestles with new pharma identity

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Malaria cases in Florida and Texas: Here’s what you need to know

entertainment

How to save PrEP access — and even expand it

Alnylam reports growth in sales of rare disease treatments

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Group behind ProMed defends move to subscription

Medical leaders decry Supreme Court decision on affirmative action

Personalized medicine goes far beyond genetics

hotspot

entertainment

Wikipedia

Wikipedia